SRPT
Price
$18.24
Change
+$0.05 (+0.27%)
Updated
Jul 3 closing price
Capitalization
1.79B
24 days until earnings call
TECX
Price
$21.34
Change
+$0.25 (+1.19%)
Updated
Jul 3 closing price
Capitalization
398.47M
Interact to see
Advertisement

SRPT vs TECX

Header iconSRPT vs TECX Comparison
Open Charts SRPT vs TECXBanner chart's image
Sarepta Therapeutics
Price$18.24
Change+$0.05 (+0.27%)
Volume$2.48M
Capitalization1.79B
Tectonic Therapeutic
Price$21.34
Change+$0.25 (+1.19%)
Volume$35.94K
Capitalization398.47M
SRPT vs TECX Comparison Chart in %
Loading...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SRPT vs. TECX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRPT is a Hold and TECX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (SRPT: $18.24 vs. TECX: $21.34)
Brand notoriety: SRPT: Notable vs. TECX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SRPT: 46% vs. TECX: 18%
Market capitalization -- SRPT: $1.79B vs. TECX: $398.47M
SRPT [@Biotechnology] is valued at $1.79B. TECX’s [@Biotechnology] market capitalization is $398.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRPT’s FA Score shows that 0 FA rating(s) are green whileTECX’s FA Score has 1 green FA rating(s).

  • SRPT’s FA Score: 0 green, 5 red.
  • TECX’s FA Score: 1 green, 4 red.
According to our system of comparison, TECX is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRPT’s TA Score shows that 4 TA indicator(s) are bullish while TECX’s TA Score has 4 bullish TA indicator(s).

  • SRPT’s TA Score: 4 bullish, 4 bearish.
  • TECX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, SRPT is a better buy in the short-term than TECX.

Price Growth

SRPT (@Biotechnology) experienced а +5.86% price change this week, while TECX (@Biotechnology) price change was +6.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

SRPT is expected to report earnings on Oct 29, 2025.

TECX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($1.79B) has a higher market cap than TECX($398M). TECX YTD gains are higher at: -53.780 vs. SRPT (-84.999). TECX has higher annual earnings (EBITDA): -56.94M vs. SRPT (-106.51M). SRPT has more cash in the bank: 523M vs. TECX (306M). TECX has less debt than SRPT: TECX (2.63M) vs SRPT (1.34B). SRPT has higher revenues than TECX: SRPT (2.23B) vs TECX (0).
SRPTTECXSRPT / TECX
Capitalization1.79B398M451%
EBITDA-106.51M-56.94M187%
Gain YTD-84.999-53.780158%
P/E Ratio27.21N/A-
Revenue2.23B0-
Total Cash523M306M171%
Total Debt1.34B2.63M51,064%
FUNDAMENTALS RATINGS
SRPT vs TECX: Fundamental Ratings
SRPT
TECX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
22
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9493
PRICE GROWTH RATING
1..100
9859
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECX's Valuation (22) in the null industry is somewhat better than the same rating for SRPT (62) in the Biotechnology industry. This means that TECX’s stock grew somewhat faster than SRPT’s over the last 12 months.

TECX's Profit vs Risk Rating (100) in the null industry is in the same range as SRPT (100) in the Biotechnology industry. This means that TECX’s stock grew similarly to SRPT’s over the last 12 months.

TECX's SMR Rating (93) in the null industry is in the same range as SRPT (94) in the Biotechnology industry. This means that TECX’s stock grew similarly to SRPT’s over the last 12 months.

TECX's Price Growth Rating (59) in the null industry is somewhat better than the same rating for SRPT (98) in the Biotechnology industry. This means that TECX’s stock grew somewhat faster than SRPT’s over the last 12 months.

TECX's P/E Growth Rating (100) in the null industry is in the same range as SRPT (100) in the Biotechnology industry. This means that TECX’s stock grew similarly to SRPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SRPTTECX
RSI
ODDS (%)
Bullish Trend 4 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
77%
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bearish Trend 4 days ago
76%
Bearish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
79%
Bearish Trend 10 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
68%
Bearish Trend 4 days ago
87%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGKZX28.920.41
+1.44%
PGIM Jennison Technology Z
UBVCX75.660.42
+0.56%
Undiscovered Managers Behavioral Val C
ECDIX18.250.06
+0.33%
Eaton Vance Global Equity Income C
MICYX9.530.02
+0.21%
Victory Trivalent Intl Fd-Core Eq Y
SPMVX9.27N/A
-0.04%
Invesco SteelPath MLP Select 40 R5

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with ALZN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
+0.25%
ALZN - SRPT
49%
Loosely correlated
-2.00%
AXON - SRPT
43%
Loosely correlated
+2.70%
SYRE - SRPT
41%
Loosely correlated
+1.68%
XNCR - SRPT
41%
Loosely correlated
+1.45%
DYN - SRPT
40%
Loosely correlated
-2.01%
More

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with IGC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then IGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
+1.19%
IGC - TECX
49%
Loosely correlated
-1.47%
LPTX - TECX
39%
Loosely correlated
+1.18%
ATHE - TECX
37%
Loosely correlated
+2.64%
IMNM - TECX
36%
Loosely correlated
+2.43%
SRPT - TECX
35%
Loosely correlated
+0.25%
More